+1 862-686-2696

  • Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Human Mobilized Peripheral Blood CD133+ Cells

  • For research use only

Cat No.

ABC-TC3896
Product Type

Immune Cells
Cell Type

CD133+
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Normal
Storage

Liquid Nitrogen

The Mobilized Human CD133+ Cells from peripheral blood are ideal for stem cell therapy, angiogenesis, and regenerative medicine applications.

Product Image
  • Human Mobilized Peripheral Blood CD133+ Cells
Get a Quote
Home | Primary Cells | Human Primary Cells | Immune System Primary Cells | Human Mobilized Peripheral Blood CD133+ Cells

Description

Human Mobilized Peripheral Blood CD133+ Cells are isolated from granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood, enriching hematopoietic stem/progenitor cells (HSPCs) with regenerative potential. These cells exhibit heterogeneous morphology, ranging from small round lymphocytes to larger progenitor-like blasts. They possess self-renewal capacity and hematopoietic differentiation, in vitro endothelial differentiation is limited to specific cytokine-driven conditions. They express the prominin-1/CD133 as a key surface marker. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

Human Mobilized Peripheral Blood CD133+ Cells, Mobilized CD133+ Cells, Peripheral Blood Stem/Progenitor Cells CD133+, mPB CD133+ Cells
Species

Human
Cat.No

ABC-TC3896
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

CD133+
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Peripheral Blood
Disease

Normal
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Immune Cells
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Mobilized Peripheral Blood CD133+ Cells have significant therapeutic potential, particularly in regenerative medicine and oncology. These progenitor cells are investigated for their ability to promote vascular repair and tissue regeneration in ischemic conditions, such as myocardial infarction, stroke, and critical limb ischemia. Their capacity to differentiate into endothelial cells and secrete angiogenic factors makes them promising candidates for cell-based therapies aimed at restoring blood flow and repairing damaged tissues.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Human Mobilized Peripheral Blood CD133+ Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button